SCHEMBL7401023

SCHEMBL7401023

CCOC(=O)CCNC(=O)c1cc(OCCCNC(=O)OC(C)(C)C)no1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 1/20 0.45
KDM4E B2RXH2 4/20 0.41
NPSR1 Q6W5P4 3/20 0.41
MAPT P10636 3/20 0.41
POLB P06746 3/20 0.40
CYP2C19 P33261 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
GABRA5 P31644 1/20 0.39
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7401084 0.83 SMPD1 (0.50) SMPD1KDM4EMAPTPOLBCYP2C19
SCHEMBL7400566 0.81 CA12 (0.46) SMPD1NPSR1MAPTCYP2C19CA12
SCHEMBL8620461 0.81 CTSK (0.40) SMPD1KDM4ENPSR1MAPTPOLB
SCHEMBL7403157 0.81 SMPD1 (0.43) SMPD1KDM4EMAPTPOLBCYP2C19
SCHEMBL7403280 0.80 CA12 (0.45) SMPD1CYP2C19CYP3A4CA12CA1
SCHEMBL7403152 0.79 ITGB3 (0.45) SMPD1POLB
SCHEMBL8650087 0.78 CA12 (0.44) SMPD1NPSR1CYP2C19CA12CA1
SCHEMBL1784924 0.74 CTSK (0.51) KDM4ENPSR1MAPTCYP2C19CYP1A2
SCHEMBL8532598 0.74 POLB (0.54) KDM4EMAPTPOLBCYP2C19CYP1A2
SCHEMBL7400723 0.73 SYK (0.50) NPSR1MAPTPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0828737-A1 ISOXAZOLINE AND ISOXAZOLE DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-03-18 EP disclosed
WO-1996037492-A1 ISOXAZOLINE AND ISOXAZOLE DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-11-28 WO disclosed